Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
Conditions: Non-Alcoholic Fatty Liver Disease; Type2diabetes Interventions: Drug: Empagliflozin 10 MG; Drug: Pioglitazone 15mg; Drug: Metformin Sponsor: Jinnah Postgraduate Medical Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Condition: Cardiogenic Shock Intervention: Drug: Empagliflozin 10 MG Sponsor: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials